Randal W. Scott insider trades: BridgeBio Pharma (BBIO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randal reports to the SEC
Open-market buys and sales
78 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | BBIO | ↓ Sell | 10,000 | $67.15 | $671K | Direct | May 19, 2026 (4d) |
| Feb 17, 2026 | BBIO | ↓ Sell | 10,000 | $75.46 | $755K | Direct | Feb 18, 2026 (1d) |
| Nov 17, 2025 | BBIO | ↓ Sell | 10,000 | $66.65 | $666K | Direct | Nov 19, 2025 (2d) |
| Jun 4, 2024 | BBIO | ↓ Sell | 2,500 | $30.32 | $76K | By Thinking Bench Capital LLC | Jun 5, 2024 (1d) |
| Mar 1, 2024 | BBIO | ↓ Sell | 2,500 | $34.00 | $85K | By Thinking Bench Capital LLC | Mar 5, 2024 (4d) |
| Dec 18, 2023 | BBIO | ↓ Sell | 2,000 | $40.00 | $80K | Indirect | Dec 20, 2023 (2d) |
| Dec 1, 2023 | BBIO | ↓ Sell | 2,500 | $29.40 | $74K | Indirect | Dec 5, 2023 (4d) |
| Sep 5, 2023 | BBIO | ↓ Sell | 2,500 | $30.00 | $75K | Indirect | Sep 7, 2023 (2d) |
| May 17, 2021 | TLIS | ↑ Buy | 20,000 | $10.13 | $203K | Direct | May 18, 2021 (1d) |
| Feb 17, 2021 | TLIS | ↑ Buy | 312,500 | $16.00 | $5.0M | By OG Family Trust, u/d/t May 30, 2014 | Feb 19, 2021 (2d) |
| Feb 17, 2021 | BBIO | ↑ Buy | 16,000 | $62.50 | $1.0M | Direct | Feb 18, 2021 (1d) |
| Aug 26, 2019 | NVTA | ↓ Sell | 40,000 | $24.59 | $983K | By OG Family Trust | Aug 27, 2019 (1d) |
| May 28, 2019 | NVTA | ↓ Sell | 30,000 | $17.60 | $528K | By OG Family Trust | May 30, 2019 (2d) |
| Feb 25, 2019 | NVTA | ↓ Sell | 30,000 | $19.10 | $573K | By OG Family Trust | Feb 27, 2019 (2d) |
| Apr 2, 2018 | NVTA | ↑ Buy | 44,444 | $4.50 | $200K | Randall W. Scott and Eileen M. Scott, Tr | Apr 2, 2018 (0d) |
| Nov 22, 2016 | NVTA | ↑ Buy | 66,666 | $6.00 | $400K | Direct | Nov 22, 2016 (0d) |
| Jul 11, 2012 | GHDX | ↓ Sell | 30,000 | $35.39 | $1.1M | Direct | Jul 12, 2012 (1d) |
| Jun 12, 2012 | GHDX | ↓ Sell | 30,000 | $33.54 | $1.0M | Direct | Jun 13, 2012 (1d) |
| May 11, 2012 | GHDX | ↓ Sell | 30,000 | $30.22 | $907K | Direct | May 14, 2012 (3d) |
| Apr 11, 2012 | GHDX | ↓ Sell | 20,000 | $28.59 | $572K | Direct | Apr 12, 2012 (1d) |
| Mar 13, 2012 | GHDX | ↓ Sell | 30,000 | $31.05 | $931K | Direct | Mar 14, 2012 (1d) |
| Feb 10, 2012 | GHDX | ↓ Sell | 20,000 | $26.18 | $524K | Direct | Feb 13, 2012 (3d) |
| Jan 11, 2012 | GHDX | ↓ Sell | 20,000 | $27.46 | $549K | Direct | Jan 12, 2012 (1d) |
| Dec 13, 2011 | GHDX | ↓ Sell | 20,000 | $27.29 | $546K | Direct | Dec 14, 2011 (1d) |
| Nov 11, 2011 | GHDX | ↓ Sell | 20,000 | $27.24 | $545K | Direct | Nov 14, 2011 (3d) |
| Oct 11, 2011 | GHDX | ↓ Sell | 20,000 | $22.83 | $457K | Direct | Nov 22, 2011 (42d) |
| Sep 13, 2011 | GHDX | ↓ Sell | 20,000 | $20.81 | $416K | Direct | Sep 14, 2011 (1d) |
| Aug 11, 2011 | GHDX | ↓ Sell | 20,000 | $24.44 | $489K | Direct | Aug 12, 2011 (1d) |
| Jul 12, 2011 | GHDX | ↓ Sell | 20,000 | $27.36 | $547K | Direct | Jul 13, 2011 (1d) |
| Jun 13, 2011 | GHDX | ↓ Sell | 20,000 | $25.69 | $514K | Direct | Jun 14, 2011 (1d) |
| May 11, 2011 | GHDX | ↓ Sell | 20,000 | $26.66 | $533K | Direct | May 11, 2011 (0d) |
| Apr 12, 2011 | GHDX | ↓ Sell | 20,000 | $25.96 | $519K | Direct | Apr 13, 2011 (1d) |
| Mar 11, 2011 | GHDX | ↓ Sell | 20,000 | $25.62 | $512K | Direct | Mar 14, 2011 (3d) |
| Feb 11, 2011 | GHDX | ↓ Sell | 20,000 | $22.20 | $444K | Direct | Feb 14, 2011 (3d) |
| Jan 11, 2011 | GHDX | ↓ Sell | 20,000 | $21.73 | $435K | Direct | Jan 12, 2011 (1d) |
| Dec 13, 2010 | GHDX | ↓ Sell | 20,000 | $22.46 | $449K | Direct | Dec 14, 2010 (1d) |
| Nov 11, 2010 | GHDX | ↓ Sell | 20,000 | $18.27 | $365K | Direct | Nov 12, 2010 (1d) |
| Oct 12, 2010 | GHDX | ↓ Sell | 20,000 | $13.95 | $279K | Direct | Oct 13, 2010 (1d) |
| Sep 13, 2010 | GHDX | ↓ Sell | 20,000 | $14.87 | $297K | Direct | Sep 14, 2010 (1d) |
| Aug 11, 2010 | GHDX | ↓ Sell | 20,000 | $14.71 | $294K | Direct | Aug 12, 2010 (1d) |
| Jul 13, 2010 | GHDX | ↓ Sell | 20,000 | $12.81 | $256K | Direct | Jul 14, 2010 (1d) |
| Jun 11, 2010 | GHDX | ↓ Sell | 20,000 | $14.15 | $283K | Direct | Jun 11, 2010 (0d) |
| May 11, 2010 | GHDX | ↓ Sell | 20,000 | $15.61 | $312K | Direct | May 12, 2010 (1d) |
| Apr 13, 2010 | GHDX | ↓ Sell | 20,000 | $16.87 | $337K | Direct | Apr 13, 2010 (0d) |
| Mar 11, 2010 | GHDX | ↓ Sell | 20,000 | $19.30 | $386K | Direct | Mar 12, 2010 (1d) |
| Feb 11, 2010 | GHDX | ↓ Sell | 20,000 | $17.23 | $345K | Direct | Feb 12, 2010 (1d) |
| Dec 11, 2009 | GHDX | ↓ Sell | 12,000 | $20.24 | $243K | Direct | Dec 14, 2009 (3d) |
| Nov 11, 2009 | GHDX | ↓ Sell | 12,000 | $19.99 | $240K | Direct | Nov 12, 2009 (1d) |
| Oct 13, 2009 | GHDX | ↓ Sell | 12,000 | $20.66 | $248K | Direct | Oct 14, 2009 (1d) |
| Sep 11, 2009 | GHDX | ↓ Sell | 12,000 | $20.67 | $248K | Direct | Sep 14, 2009 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BBIO insiders
Open-market trades in the last 12 months
About Randal W. Scott's insider trades
Randal W. Scott is a director at BridgeBio Pharma (BBIO). Since Feb 13, 2007, Randal has reported 5 open-market purchases worth $6.8M and 73 sales worth $27.3M on SEC Form 4. In the last 12 months: 3 sales ($2.1M).
Their filings also include grants and awards (21 filings), option exercises (5 filings), gifts (4 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.